MPP And WHO Announce COVID Technology License Via C-TAP
Serological Antibody Technology Deal Struck With Spanish National Research Council
The WHO and Medicines Patent Pool have announced “the first transparent, global, non-exclusive license for a COVID-19 technology” after striking a deal for a COVID-19 serological antibody technology with the Spanish National Research Council through the WHO’s COVID-19 Technology Access Pool.
